Biohaven Shares Outstanding History (BHVN)
Biohaven reported 132.8M shares outstanding at the end of fiscal 2025.
View full Biohaven company overviewBiohaven annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 132.8M | 31.6M | +31.17% |
| 2024 | 2024-12-31 | 101.2M | 20.1M | +24.79% |
| 2023 | 2023-12-31 | 81.1M | 12.9M | +18.95% |
| 2022 | 2022-12-31 | 68.2M | 68.2M | — |
| 2021 | 2021-12-31 | 0 | — | — |
Biohaven quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 151.0M | 45.2M | +42.76% |
| Q1 2026 | 2026-03-31 | 150.5M | 48.4M | +47.41% |
| Q4 2025 | 2025-12-31 | 132.8M | 31.6M | +31.17% |
| Q3 2025 | 2025-09-30 | 105.8M | 10.9M | +11.49% |
| Q2 2025 | 2025-06-30 | 105.8M | 13.4M | +14.55% |
| Q1 2025 | 2025-03-31 | 102.1M | 20.3M | +24.81% |
| Q4 2024 | 2024-12-31 | 101.2M | 20.1M | +24.79% |
| Q3 2024 | 2024-09-30 | 94.9M | 26.5M | +38.81% |
| Q2 2024 | 2024-06-30 | 92.3M | 24.0M | +35.17% |
| Q1 2024 | 2024-03-31 | 81.8M | 13.6M | +19.93% |
| Q4 2023 | 2023-12-31 | 81.1M | 12.9M | +18.95% |
| Q3 2023 | 2023-09-30 | 68.4M | 68.4M | +136728186.00% |
| Q2 2023 | 2023-06-30 | 68.3M | 68.3M | — |
| Q1 2023 | 2023-03-31 | 68.2M | — | — |
| Q4 2022 | 2022-12-31 | 68.2M | — | — |
| Q3 2022 | 2022-09-30 | 50 | — | — |
| Q4 2021 | 2021-12-31 | 0 | — | — |
Biohaven shares outstanding trends
Across the available reported history, Biohaven's shares outstanding moved from 101.2M to 132.8M, a change of 31.6M. The latest reported quarter, Q2 2026, shows 151.0M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven filings at SEC.gov ↗